Literature DB >> 21198793

Evidence for the absence of mutations at GJB3, GJB4 and LOR in progressive symmetrical erythrokeratodermia.

S Wei1, Y Zhou, T D Zhang, Z M Huang, X B Zhang, H L Zhu, B H Liang, L Lin, L Deng.   

Abstract

BACKGROUND: Progressive symmetrical erythrokeratodermia (PSEK) is a rare inherited cornification disorder characterized by symmetrical erythematous hyperkeratotic plaques. The genetic basis for PSEK is not clear. PSEK shares many clinical features with erythrokeratodermia variabilis (EKV), which is associated with mutations in genes coding for gap junction beta (GJB) 3 and 4. A mutation in the loricrin gene (LOR) was found in patients with PSEK, who were members of a family with Vohwinkel syndrome. It would therefore be of interest to determine if PSEK is also caused by mutations in these genes. AIM: To examine the mutation status of GJB3, GJB4 and LOR in patients with PSEK and in control subjects.
METHODS: Genomic DNA samples from 25 patients with PSEK and 56 healthy controls were examined by sequencing analysis of the coding sequences of GJB3, GJB4 and LOR.
RESULTS: There were no mutations found in any of these three genes.
CONCLUSIONS: PSEK is a disorder distinct from EKV, and the true pathogenesis of PSEK remains unknown. © The Author(s). CED
© 2010 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2010        PMID: 21198793     DOI: 10.1111/j.1365-2230.2010.03974.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  Identification of a CDH12 potential candidate genetic variant for an autosomal dominant form of transgrediens and progrediens palmoplantar keratoderma in a Tunisian family.

Authors:  Cherine Charfeddine; Hamza Dallali; Ghaith Abdessalem; Kais Ghedira; Yosr Hamdi; Sahar Elouej; Zied Landoulsi; Valérie Delague; Arnaud Lagarde; Nicolas Levy; Aziz El-Amraoui; Mohamed Samir Boubaker; Sonia Abdelhak; Mourad Mokni
Journal:  J Hum Genet       Date:  2020-01-07       Impact factor: 3.172

2.  Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia.

Authors:  Lynn M Boyden; Brittany G Craiglow; Jing Zhou; Ronghua Hu; Erin C Loring; Kimberly D Morel; Christine T Lauren; Richard P Lifton; Kaya Bilguvar; Amy S Paller; Keith A Choate
Journal:  J Invest Dermatol       Date:  2014-11-14       Impact factor: 8.551

3.  Progressive symmetric erythrokeratodermia with delayed intellectual milestones and convulsions.

Authors:  Shyam B Verma; Uwe Wollina
Journal:  Indian Dermatol Online J       Date:  2012-01

4.  Progressive Symmetric Erythrokeratoderma Having Overlapping Features With Erythrokeratoderma Variabilis and Lesional Hypertrichosis: Is Nomenclature "Erythrokeratoderma Variabilis Progressiva" More Appropriate?

Authors:  Vikram K Mahajan; Gayatri Khatri; Pushpinder S Chauhan; Karaninder S Mehta; Rashmi Raina; Mrinal Gupta
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.